bioAffinity Technologies (BIAF) Convertible Debt (2021 - 2022)
bioAffinity Technologies (BIAF) reported Convertible Debt of $325000.0 for Q4 2022, down 87.5% year-over-year from $2.6 million in Q4 2021, and down 87.5% quarter-over-quarter from $2.6 million in Q3 2022.
bioAffinity Technologies (BIAF) Convertible Debt (2021 - 2022) Analysis & Trends
bioAffinity Technologies (BIAF) has 2 years of Convertible Debt data on file, last reported at $325000.0 in Q4 2022.
- Convertible Debt for Q4 2022 came in at $325000.0, down 87.5% year-over-year; the trailing twelve-month figure through Dec 2022 was $325000.0 (down 87.5% YoY), and the FY2022 annual result was $325000.0, down 87.5% from the prior year.
- Convertible Debt declined to $325000.0 in Q4 2022 per BIAF's latest filing, from $2.6 million in the prior quarter.
- Over five years, Convertible Debt peaked at $2.6 million in Q4 2021 and troughed at $325000.0 in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn |
| 10 | bioAffinity Technologies | 2.08 Mn | -1.02 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 325,000.00 |
| Sep 30, 2022 | 2.60 Mn |
| Mar 31, 2022 | 2.60 Mn |
| Dec 31, 2021 | 2.60 Mn |
| Sep 30, 2021 | 900,000.00 |